Status:
WITHDRAWN
Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers
Lead Sponsor:
University of California, San Francisco
Conditions:
Gastrointestinal Cancers
Gastrointestinal Cancer Metastatic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized trial of patients with gastrointestinal (GI) cancers treated at University of California, San Francisco (UCSF) who are starting a new line of systemic therapy to evaluate the feas...
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate the feasibility of the ePRO platform by describing the proportion of participants who engage with the ePRO tool via virtual care chat at least once after enrollment...
Eligibility Criteria
Inclusion
- Age 18 years and older
- Diagnosis of gastrointestinal cancers: esophageal, gastric, hepatocellular carcinoma, cholangiocarcinoma, pancreatic, neuroendocrine, small intestine, colorectal and anal cancers.
- Patients can have early stage or advanced cancer and will be starting treatment with new, standard of care infusion therapy regimen at UCSF.
- Ability to understand study procedures and to comply with them for the entire length of the study.
- No limit on prior lines of therapy.
- Access to smartphone, tablet, or computer with capability to use symptom tracking web site (must have mobile phone number or email address).
- Willing and able to provide written, signed informed consent in English.
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
Exclusion
- Patients who have already started therapy prior to study enrollment.
- Patients who are receiving their treatment outside of UCSF.
- Participation in another clinical trial (therapeutic or non-therapeutic).
- Patients who are on therapy with oral oncolytics or combination therapy of oral oncolytics and infusional agents.
- Patients who are non-English speakers.
Key Trial Info
Start Date :
June 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05359042
Start Date
June 15 2024
End Date
December 30 2024
Last Update
May 8 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.